Production of human UDP-glucuronosyltransferases 1A6 and 1A9 using the Semliki Forest virus expression system

被引:6
|
作者
Forsman, T
Lautala, P
Lundström, K
Monastyrskaia, K
Ouzzine, M
Burchell, B
Taskinen, J
Ulmanen, I
机构
[1] Univ Helsinki, Orion Pharma, Bioctr 1A, Mol Biol & Target Prot Res, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Dept Pharm, Div Pharmaceut Chem, FIN-00014 Helsinki, Finland
[3] Roche Ltd, F Hoffmann La Roche, Res Labs, Basel, Switzerland
[4] Givaudan Roure Forsch AG, Dubendorf, Switzerland
[5] Univ Nancy 1, CNRS, UMR 7561, F-54506 Vandoeuvre Nancy, France
[6] Univ Dundee, Ninewells Hosp & Med Sch, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland
[7] Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland
关键词
Semliki Forest virus system; UDP-glucuronosyltransferases UGT1A6 and UGT1A9; mammalian cell expression; RT-PCR;
D O I
10.1016/S0024-3205(00)00831-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Human UDP-glucuronosyltransferases (UGTs) 1A6 and 1A9 were expressed using Semliki Forest virus (SFV) vectors. Infection of chinese hamster lung fibroblast V79 cells with recombinant SFV-UGT viruses resulted in efficient protein expression as detected by metabolic labeling, Western blot analyses and immunofluorescence microscopy. The expression of UGT1A6 and UGT1A9 in the SFV-infected cells was approximately two fold higher than in a stable V79 cell line. No UGT signal was detected in noninfected cells. In addition, SFV-UGT viruses also efficiently infected other mammalian cells, such as baby hamster kidney (BHK), chinese hamster ovary (CHO) and human lung (WI-26 VA4) cells leading to high production of recombinant enzyme. The measurement of enzyme activities and kinetic parameters using p-nitrophenol and nitrocatechol (entacapone) as substrates for UGT1A6 and UGT1A9, respectively, showed that the overall kinetic properties of the enzymes produced by the two systems were similar. We conclude that the SFV expression system represents an efficient, fast and versatile method for production of metabolic enzymes for in vitro assays. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:2473 / 2484
页数:12
相关论文
共 50 条
  • [21] Dual polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: a novel mechanism for hyperserotoninaemia in Gilbert's syndrome mimicking carcinoid syndrome?
    Lee, Paul
    Jones, Graham
    Seibela, Markus J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (04) : 337 - 340
  • [22] UDP-glucuronosyltransferases 1A expression in human urinary bladder and colon cancer by immunohistochemistry
    Giuliani, L
    Ciotti, M
    Stoppacciaro, A
    Pasquini, A
    Silvestri, I
    de Matteis, A
    Frati, L
    Aglianò, AM
    ONCOLOGY REPORTS, 2005, 13 (02) : 185 - 191
  • [23] Bovine Serum Albumin Decreases Km Values of Human UDP-Glucuronosyltransferases 1A9 and 2B7 and Increases Vmax Values of UGT1A9
    Manevski, Nenad
    Moreolo, Paolo Svaluto
    Yli-Kauhaluoma, Jari
    Finel, Moshe
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (11) : 2117 - 2129
  • [24] GLUCURONIDATION OF SARPOGRELATE ACTIVE METABOLITE (M1) IS MEDIATED BY UDP-GLUCURONOSYLTRANSFERASES 1A4, 1A9 AND 2B4
    Kim, Dong-Hyun
    Shin, Jae-Gook
    Kim, Hyo-Ji
    Jeong, Eun-Sook
    Seo, Kyung-Ah
    Shin, Jae-Gook
    Kim, Dong-Hyun
    DRUG METABOLISM REVIEWS, 2012, 44 : 50 - 50
  • [25] Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A9, and 2B7 and Impacts on Glucuronidation Activity
    Yuan, Ling-Min
    Gao, Zhang-Zhao
    Sun, Hong-Ying
    Qian, Sai-Nan
    Xiao, Yong-Sheng
    Sun, Lian-Li
    Zeng, Su
    SCIENTIFIC REPORTS, 2016, 6
  • [26] Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A9 and 2B7 and Impacts on Glucuronidation Activity
    Ling-Min Yuan
    Zhang-Zhao Gao
    Hong-Ying Sun
    Sai-Nan Qian
    Yong-Sheng Xiao
    Lian-Li Sun
    Su Zeng
    Scientific Reports, 6
  • [27] High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human
    Akazawa, Takanori
    Uchida, Yasuo
    Miyauchi, Eisuke
    Tachikawa, Masanori
    Ohtsuki, Sumio
    Terasaki, Tetsuya
    MOLECULAR PHARMACEUTICS, 2018, 15 (01) : 127 - 140
  • [28] Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferases
    Luukkanen, L
    Taskinen, J
    Kurkela, M
    Kostiainen, R
    Hirvonen, J
    Finel, M
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (07) : 1017 - 1026
  • [29] Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS
    Joo, Jeongmin
    Kim, Yang-Weon
    Wu, Zhexue
    Shin, Jung-Hoon
    Lee, Boram
    Shon, Jong Cheol
    Lee, Eun Young
    Nguyen Minh Phuc
    Liu, Kwang-Hyeon
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2015, 36 (04) : 258 - 264
  • [30] THE EXPRESSION OF UDP-GLUCURONOSYLTRANSFERASES OF THE UGT1 FAMILY IN HUMAN LIVER AND KIDNEY AND IN RESPONSE TO DRUGS
    SUTHERLAND, L
    EBNER, T
    BURCHELL, B
    BIOCHEMICAL PHARMACOLOGY, 1993, 45 (02) : 295 - 301